Anais Andrillon
Tournus, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dose optimization for cancer treatments with considerations for late-onset toxicities.
Journal: Clinical trials (London, England)
Published: April 09, 2024
Incorporating patient-reported outcomes in dose-finding clinical trials with continuous patient enrollment.
Journal: Journal of biopharmaceutical statistics
Published: July 27, 2023
Surv-CRM-12: A Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression.
Journal: Statistics in medicine
Published: December 16, 2021
Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome.
Journal: The British journal of dermatology
Published: November 04, 2021
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients.
Journal: American journal of ophthalmology
Published: October 24, 2021
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.
Journal: Ophthalmology
Published: June 18, 2021
Dose-finding design and benchmark for a right censored endpoint.
Journal: Journal of biopharmaceutical statistics
Published: November 23, 2020
Performance of propensity score matching to estimate causal effects in small samples.
Journal: Statistical methods in medical research
Published: March 19, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026